Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
- Submitting institution
-
Liverpool School of Tropical Medicine
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 71
- Type
- D - Journal article
- DOI
-
10.1016/S2352-3018(20)30050-3
- Title of journal
- The Lancet HIV
- Article number
- -
- First page
- e332
- Volume
- 7
- Issue
- 5
- ISSN
- 2352-3018
- Open access status
- Access exception
- Month of publication
- -
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
-
- Research group(s)
-
-
- Citation count
- 10
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution to carrying out the study. b. The author helped draft the output; critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -